S

Sumitomo Pharma America

Develops medicines for cancer and chronic diseases

Associate Director - Biostatistics

Quantitative Biology & BiostatisticsConfirmed live in the last 24 hours
Full-timeRemote in USA

About the Job

Requirements

  • Broad and current knowledge of statistical principles, clinical-trial methodology, and their application throughout drug development.
  • Strong understanding of applicable regulatory guidance, including ICH guidelines and expectations of FDA, EMA, PMDA, and other health authorities.
  • Knowledge of relevant industry standards, including CDISC standards.
  • Proficiency in statistical computing using SAS and R.
  • Ability to communicate complex statistical concepts and recommendations clearly to technical and non-technical audiences.
  • Demonstrated ability to provide strategic leadership, influence cross-functional decisions, and manage multiple priorities in a fast-paced environment.
  • Proven ability to collaborate effectively across functions and communicate recommendations to senior leadership.
  • A PhD in Statistics, Biostatistics, or a related quantitative discipline with at least 5 years of relevant experience, or an MS with at least 8 years of relevant experience, in the pharmaceutical or biotechnology industry.
  • Significant experience providing statistical leadership for clinical development programs and clinical trials.
  • Experience overseeing CROs, vendors, or external statistical partners is required.
  • Must be able to travel domestically and internationally as needed.
  • Must be able to exercise appropriate judgment and demonstrate a high level of initiative and independence.
  • Excellent written and oral communication skills are required.
  • Requires ability to use a personal computer for extended periods.

Responsibilities

  • Serve as the biostatistics lead for one or more clinical development programs, providing strategic statistical input into clinical development plans, study designs, operational decisions, decision criteria, and analysis strategies.
  • Represent Biostatistics on cross-functional program and study teams and ensure that statistical considerations are incorporated into key development decisions.
  • Lead statistical interactions with regulatory authorities, including the planning and preparation of briefing documents, responses to regulatory questions, and discussions of statistical methodology.
  • Author or oversee the development and review of statistical sections of protocols, statistical analysis plans, regulatory submissions, publications, and other scientific documents.
  • Provide statistical interpretation of study results, communicate benefit-risk considerations, and support data-driven program decisions.
  • Identify statistical, operational, and regulatory risks and recommend practical mitigation strategies.
  • Oversee CRO and external vendor statistical activities, including scope definition, quality review, timelines, and delivery of statistical outputs.
  • Provide technical leadership, coaching, and mentorship to statisticians and statistical programmers, as appropriate.
  • Evaluate and apply innovative statistical methods, including Bayesian approaches, adaptive or complex trial designs, and quantitative decision-making methods when appropriate.
  • Contribute to departmental standards, process improvements, statistical governance, and capability development.
  • Support marketing applications and regulatory interactions.
  • Handle multiple demands in a fast-paced environment.

Desired Qualifications

  • Experience with complex trial designs, Bayesian methods, or innovative statistical approaches is preferred.
  • Experience supporting regulatory interactions and marketing applications is strongly preferred.
  • Oncology or hematology clinical development experience is preferred.

About the Company

Sumitomo Pharma America

Develops medicines for cancer and chronic diseases

Sumitomo Pharma America develops and sells prescription medicines for patients with cancer, bladder conditions, women's health disorders and other serious illnesses. Its portfolio combines established treatments with research into diseases that have limited treatment options. The business carries medicines from scientific development and clinical studies through manufacturing and commercialization, with approved products prescribed by healthcare professionals. It operates as the consolidated U.S. pharmaceutical business within Japan's Sumitomo Pharma group. The company traces its roots to 1984, took its combined form in 2023 and is headquartered in Marlborough, Massachusetts.

Company size
1,001-5,000
Company stage
Not listed
Total funding
Not listed
Headquarters
Marlborough, MA
Founded
1984

Recently Posted Jobs

Explore more opportunities at Sumitomo Pharma America

See more jobs